Adjuvant therapy for grade 3, deeply invasive endometrioid adenocarcinoma of the uterus.

MLA

Onstad, Michaela, et al. “Adjuvant Therapy for Grade 3, Deeply Invasive Endometrioid Adenocarcinoma of the Uterus.” International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, vol. 30, no. 4, Apr. 2020, pp. 485–90. EBSCOhost, https://doi.org/10.1136/ijgc-2019-000807.

APA

Onstad, M., Ducie, J., Fellman, B. M., Abu-Rustum, N. R., Leitao, M., Mariani, A., Multinu, F., Lu, K. H., & Soliman, P. (2020). Adjuvant therapy for grade 3, deeply invasive endometrioid adenocarcinoma of the uterus. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, 30(4), 485–490. https://doi.org/10.1136/ijgc-2019-000807

Chicago

Onstad, Michaela, Jennifer Ducie, Bryan M Fellman, Nadeem R Abu-Rustum, Mario Leitao, Andrea Mariani, Francesco Multinu, Karen H Lu, and Pamela Soliman. 2020. “Adjuvant Therapy for Grade 3, Deeply Invasive Endometrioid Adenocarcinoma of the Uterus.” International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society 30 (4): 485–90. doi:10.1136/ijgc-2019-000807.